Issued Patents All Time
Showing 1–16 of 16 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12421319 | Binding agents that bind OX40 (CD134) and method of use thereof to treat disease | Ugur Sahin, Friederike Gieseke, David Satijn, Paul Parren | 2025-09-23 |
| 12077596 | Multispecific antibodies against CD40 and CD137 | David Satijn, Rik RADEMAKER, Paul Parren, Friederike Gieseke, Ugur Sahin | 2024-09-03 |
| 11939388 | Multispecific antibodies against CD40 and CD137 | David Satijn, Rik RADEMAKER, Paul Parren, Friederike Gieseke, Ugur Sahin | 2024-03-26 |
| 11814411 | Nucleic acid molecules encoding binding agents to CD40 and 4-1BB (CD137) | Ugur Sahin, Friederike Gieseke, David Satijn, Paul Parren | 2023-11-14 |
| 11613575 | Humanized or chimeric CD3 antibodies | Edward Norbert Van Den Brink, Joost J. NEIJSSEN, Aran Frank Labrijn, Joyce I. Meesters, Janine Schuurman +2 more | 2023-03-28 |
| 11459395 | Binding agents binding to PD-L1 and CD137 and use thereof | David Satijn, Rik RADEMAKER, Paul Parren, Ugur Sahin, Friederike Gieseke +4 more | 2022-10-04 |
| 11440966 | Multispecific antibodies against CD40 and CD137 | David Satijn, Rik RADEMAKER, Paul Parren, Friederike Gieseke, Ugur Sahin | 2022-09-13 |
| 11359015 | Humanized or chimeric CD3 antibodies | Rik RADEMAKER, Patrick ENGELBERTS, Janine Schuurman, Paul Parren | 2022-06-14 |
| 11091557 | Methods of producing multispecific antibodies against CD40 and CD137 | David Satijn, Rik RADEMAKER, Paul Parren, Friederike Gieseke, Ugur Sahin | 2021-08-17 |
| 11084882 | Multispecific antibodies against CD40 and CD137 | David Satijn, Rik RADEMAKER, Paul Parren, Friederike Gieseke, Ugur Sahin | 2021-08-10 |
| 10968280 | Binding agents binding to PD-L1 and CD137 and use thereof | David Satijn, Rik RADEMAKER, Paul Parren, Ugur Sahin, Friederike Gieseke +2 more | 2021-04-06 |
| 10927181 | Agonistic tumor necrosis factor (TNF) receptor binding agents | Ugur Sahin, Friederike Gieseke, David Satijn, Paul Parren | 2021-02-23 |
| 10544220 | Bispecific antibodies against CD3 and CD20 | Patrick ENGELBERTS, Esther BREIJ, Rik RADEMAKER, David Satijn, Sandra VERPLOEGEN +4 more | 2020-01-28 |
| 10457735 | Methods of inducing T cell activation by administering an antibody comprising CD40 and 4-1BB (CD137) binding domains | Ugur Sahin, Friederike Gieseke, David Satijn, Paul Parren | 2019-10-29 |
| 10407501 | Humanized or chimeric CD3 antibodies | Edward Norbert Van Den Brink, Joost J. NEIJSSEN, Aran Frank Labrijn, Joyce I. Meesters, Janine Schuurman +2 more | 2019-09-10 |
| 9339554 | Tunable, biodegradable linker molecules for transient conjugation of components in drug delivery systems, and drug delivery systems prepared therewith | Cristianne Johanna Ferdinand Rijcken, Wilhelmus Everhardus Hennink, Cornelis Franciscus Van Nostrum, Steffen van der Wal, Robertus Matthias Joseph Liskamp +1 more | 2016-05-17 |